Cancer Biotherapy and Radiopharmaceuticals
Mary Ann Liebert, Inc. · Q2
ISSN: 1084-9785 · 1557-8852
Rankings & quartile
| System | Value | Year | Source |
|---|---|---|---|
| SCImago (SJR) | 0.498 Q2 | 2025 | source |
| Citation impact (OpenAlex) | 17.4 cites/work Q3 | 2026 | source |
| h-index | 77 | 2026 | source |
Last updated 2026-05-19 · OpenAlex profile
Cite this profile
APA 7Journal Check. (2026). Cancer Biotherapy and Radiopharmaceuticals: Journal rankings & quartile. Journal Check. https://journal-check.com/journals/S87235987/cancer-biotherapy-and-radiopharmaceuticals MLA 9"Cancer Biotherapy and Radiopharmaceuticals: Journal rankings & quartile." Journal Check, 2026, https://journal-check.com/journals/S87235987/cancer-biotherapy-and-radiopharmaceuticals. Chicago 17Journal Check. "Cancer Biotherapy and Radiopharmaceuticals: Journal rankings & quartile." 2026. https://journal-check.com/journals/S87235987/cancer-biotherapy-and-radiopharmaceuticals. GB/T 7714Journal Check. Cancer Biotherapy and Radiopharmaceuticals: Journal rankings & quartile[EB/OL]. (2026). https://journal-check.com/journals/S87235987/cancer-biotherapy-and-radiopharmaceuticals.See rankings while you search
Journal Check shows this journal's quartile right next to its papers on Google Scholar, PubMed, arXiv and Semantic Scholar.
Add to Chrome — free